Showing results (11-20 of 24) with videos related to
Sort By:
Pageof 3
British Journal of Pharmacology|September 21, 2001
HS-599: a novel long acting opioid analgesic does not induce place-preference in ratsR Lattanzi, L Negri, E Giannini, et al.Life Sciences|October 23, 2001
Binding, pharmacological and immunological profiles of the delta-selective opioid receptor antagonist HS 378M Spetea, H E Harris, I P Berzetei-Gurske, et al.Die Pharmazie|February 1, 1991
(-)-N,N'-but-2-ene-1,4-diylbimorphinansH Schmidhammer, C F Smith, E Dalkner, et al.Journal of Medicinal Chemistry|April 1, 1990
Synthesis and biological evaluation of 14-alkoxymorphinans. 3. Extensive study on cyprodime-related compoundsH Schmidhammer, C F Smith, D Erlach, et al.Journal of Medicinal Chemistry|December 1, 1984
Synthesis and biological evaluation of 14-alkoxymorphinans. 1. Highly potent opioid agonists in the series of (-)-14-methoxy-N-methylmorphinan-6-onesH Schmidhammer, L Aeppli, L Atwell, et al.Archiv Der Pharmazie|January 1, 1990
An opioid agonist with preference for kappa-opioid receptors: (-)-N-cyclopropylmethylmorphinan-6-oneH Schmidhammer, E Trenker, W P Burkard, et al.Life Sciences|June 22, 1999
Opioid binding profiles of new hydrazone, oxime, carbazone and semicarbazone derivatives of 14-alkoxymorphinansK Monory, E Greiner, N Sartania, et al.Pharmacology, Biochemistry, and Behavior|January 25, 2003
Involvement of the kappa-opioid receptor in the anxiogenic-like effect of CP 55,940 in male ratsS Marín, E Marco, M Biscaia, et al.European Journal of Pharmacology|November 11, 1999
Use of selective antagonists and antisense oligonucleotides to evaluate the mechanisms of BUBU antinociceptionD M Hutcheson, P Sánchez-Blazquez, M Rodriguez-Diaz, et al.The Journal of Pharmacology and Experimental Therapeutics|December 14, 2004
Inverse agonism and neutral antagonism at wild-type and constitutively active mutant delta opioid receptorsP Tryoen-Tóth, F M Décaillot, D Filliol, et al.Pageof 3